PsychoGenics is planning the development of RO7117997 for the treatment of multiple CNS conditions starting with sleep and seizure disordersPARAMUS, N.J. (BUSINESS WIRE) PGI Drug Discovery LLC (PsychoGenics), a phenotypic drug discovery platform company, announced that it has entered into an exclusive license agre.
Accelerator will add to Manchester’s growing cyber security ecosystem, which already includes several tech unicorns, arms companies and the offices of GCHQ.